JP2009079038A5 - - Google Patents

Download PDF

Info

Publication number
JP2009079038A5
JP2009079038A5 JP2008216055A JP2008216055A JP2009079038A5 JP 2009079038 A5 JP2009079038 A5 JP 2009079038A5 JP 2008216055 A JP2008216055 A JP 2008216055A JP 2008216055 A JP2008216055 A JP 2008216055A JP 2009079038 A5 JP2009079038 A5 JP 2009079038A5
Authority
JP
Japan
Prior art keywords
topical composition
retinoic acid
composition according
topical
retinoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008216055A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009079038A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2009079038A publication Critical patent/JP2009079038A/ja
Publication of JP2009079038A5 publication Critical patent/JP2009079038A5/ja
Pending legal-status Critical Current

Links

JP2008216055A 2001-02-27 2008-08-26 表皮成長因子受容体を活性化するレチノイド療法、石鹸および他の刺激物による副作用を防止する目的での天然ｅｇｆｒ阻害剤の使用 Pending JP2009079038A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27189401P 2001-02-27 2001-02-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002567353A Division JP2005506285A (ja) 2001-02-27 2002-02-27 表皮成長因子受容体を活性化するレチノイド療法、石鹸および他の刺激物による副作用を防止する目的での天然ｅｇｆｒ阻害剤の使用

Publications (2)

Publication Number Publication Date
JP2009079038A JP2009079038A (ja) 2009-04-16
JP2009079038A5 true JP2009079038A5 (cg-RX-API-DMAC10.html) 2009-08-27

Family

ID=23037535

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002567353A Pending JP2005506285A (ja) 2001-02-27 2002-02-27 表皮成長因子受容体を活性化するレチノイド療法、石鹸および他の刺激物による副作用を防止する目的での天然ｅｇｆｒ阻害剤の使用
JP2008216055A Pending JP2009079038A (ja) 2001-02-27 2008-08-26 表皮成長因子受容体を活性化するレチノイド療法、石鹸および他の刺激物による副作用を防止する目的での天然ｅｇｆｒ阻害剤の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002567353A Pending JP2005506285A (ja) 2001-02-27 2002-02-27 表皮成長因子受容体を活性化するレチノイド療法、石鹸および他の刺激物による副作用を防止する目的での天然ｅｇｆｒ阻害剤の使用

Country Status (8)

Country Link
US (2) US6638543B2 (cg-RX-API-DMAC10.html)
EP (1) EP1370294A2 (cg-RX-API-DMAC10.html)
JP (2) JP2005506285A (cg-RX-API-DMAC10.html)
AU (1) AU2002255627B2 (cg-RX-API-DMAC10.html)
BR (1) BR0207663A (cg-RX-API-DMAC10.html)
CA (1) CA2439408C (cg-RX-API-DMAC10.html)
MX (1) MXPA03007609A (cg-RX-API-DMAC10.html)
WO (1) WO2002067988A2 (cg-RX-API-DMAC10.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US20040047828A1 (en) * 1998-08-01 2004-03-11 Merck Patent Gmbh Ectoin or ection derivatives and surfactants
US7144880B2 (en) 1999-04-30 2006-12-05 Regents Of The University Of Michigan Compositions relating to novel compounds and targets thereof
US20060025388A1 (en) * 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US7048910B2 (en) 2000-09-07 2006-05-23 Merck Patent Gmbh Use of ectoine or ectoine derivatives for oral care
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
KR100358819B1 (ko) * 2001-06-12 2002-10-25 김기홍 생약 패취제
DE10214257A1 (de) * 2002-03-28 2003-10-16 Merck Patent Gmbh Verwendung von kompatiblen Soluten zur Inhibierung der Freisetzung von Ceramiden
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
AU2003259220C1 (en) 2002-07-24 2017-08-24 Australian Health & Nutrition Association Limited Compositions and products containing enantiomeric equol, and methods for their making
EP1545451A1 (en) * 2002-09-07 2005-06-29 Johnson & Johnson Consumer France SAS Compositions comprising soy products and organic salts of certain metals
CZ2005181A3 (cs) * 2002-09-23 2005-08-17 Novogen Research Pty Ltd Léčba stárnutí pokožky vlivem světla a aktinického poškození pokožky
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
EP1569636B1 (en) 2002-10-29 2017-12-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
WO2004057330A1 (ja) * 2002-12-20 2004-07-08 Shigeki Higashiyama 細胞増殖抑制剤のスクリーニング方法および細胞増殖抑制剤
US20050096256A1 (en) * 2003-07-01 2005-05-05 President And Fellows Of Harvard College Compositions for manipulating the lifespan and stress response of cells and organisms
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
EP1708689A2 (en) * 2003-12-29 2006-10-11 The President and Fellows of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
CA2564399A1 (en) * 2004-04-28 2005-11-17 Brigham Young University Use of equol for treating skin diseases
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP2008528448A (ja) 2005-01-03 2008-07-31 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 新規化合物に関連する組成物および方法、ならびにその標的
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
US20070014833A1 (en) * 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
EP2805719A1 (en) * 2005-03-30 2014-11-26 Glaxosmithkline LLC Nicotinamide riboside and analogues thereof
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
FR2894821B1 (fr) * 2005-12-15 2008-02-29 Galderma Res & Dev Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
JP5023323B2 (ja) * 2006-06-13 2012-09-12 国立大学法人 熊本大学 アクアポリン５の発現亢進剤
JP2010504974A (ja) * 2006-09-28 2010-02-18 フォリカ，インコーポレーテッド 新しい毛嚢を生成させ毛髪を成長させる方法、キット、及び組成物
US20080118449A1 (en) * 2006-11-21 2008-05-22 Alvin Ronlan Cosmetic formulations of piceatannol and retinoids and methods of use thereof
JP5746807B2 (ja) * 2006-12-28 2015-07-08 アルロン・ジャパン株式会社 皮膚用化粧品の組成物
JP5699414B2 (ja) * 2007-02-28 2015-04-08 ユニバーシティー オブ ケンタッキー リサーチ ファウンデイション レチノイン酸療法の効力を妨げることなくレチノイン酸療法の副作用を軽減する方法、および／又は、その効力を改善する方法
US8666671B2 (en) * 2007-07-05 2014-03-04 Enhanced Pharmaceuticals, Inc. Method for determining drug-molecular combinations that modulate and enhance the therapeutic safety and efficacy of biological or pharmaceutical drugs
CA2713610C (en) * 2009-10-02 2019-08-20 Monash University Ectopic pregnancy treatment
US9126978B2 (en) 2009-11-17 2015-09-08 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
AU2019279884B2 (en) 2018-05-29 2025-01-30 Morningside Venture Investments Limited Drug delivery methods and systems
JP2022507660A (ja) 2018-11-16 2022-01-18 モーニングサイド ベンチャー インベストメンツ リミテッド 温度によって調節される経皮薬剤送達システム
JP2022515256A (ja) 2018-12-25 2022-02-17 ソル － ゲル テクノロジーズ リミテッド Ｅｇｆｒ阻害剤を含む組成物による皮膚障害の治療
KR20220041125A (ko) * 2019-07-24 2022-03-31 솔-겔 테크놀로지스 리미티드 국부 타피나로프-egfr 억제제 조성물을 이용한 피부 장애의 치료
CA3160126A1 (en) * 2019-11-06 2021-05-14 Sol-Gel Technologies Ltd. Method of treating palmoplantar keratoderma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100613A1 (en) 1982-07-09 1984-02-15 THE GENERAL ELECTRIC COMPANY, p.l.c. Signal distribution networks
JPH06312919A (ja) * 1993-05-06 1994-11-08 Kao Corp 美白剤及びこれを含有する皮膚化粧料
DE4444238A1 (de) 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
US5824702A (en) 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
US5665367A (en) * 1996-09-27 1997-09-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing naringenin and/or quercetin and a retinoid
CN1105554C (zh) * 1996-09-27 2003-04-16 尤尼利弗公司 包含能模拟视黄酸对皮肤之作用的化合物结合物的护肤组合物
AU719392B2 (en) * 1996-10-01 2000-05-11 Kyowa Hakko Kirin Co., Ltd. Nitrogen-containing heterocyclic compounds
DE19713092A1 (de) * 1997-03-27 1998-10-01 Wacker Chemie Gmbh Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
FR2782919B1 (fr) * 1998-09-04 2001-05-25 Roc Sa Composition contre le vieillissement et son utilisation
KR100332031B1 (ko) * 1999-06-03 2002-04-10 서경배 피부 주름의 개선 및 생성 억제 효과를 갖는 외용제 조성물
IL151299A0 (en) * 2000-02-16 2003-04-10 Brigham & Womens Hospital Aspirin-triggered lipid mediators

Similar Documents

Publication Publication Date Title
JP2005506285A5 (cg-RX-API-DMAC10.html)
EA200801602A1 (ru) Эмульсия
EA201171079A1 (ru) Пенообразующая композиция для местного применения
CA2439408A1 (en) Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor
ECSP12012252A (es) Inhibición de irritación sensorial durante el consumo de productos de tabaco no fumables
BRPI0410859A (pt) concentrado de carotenóide purificado, composição de carotenóide purificada diluìda, composição adequada para administração oral, substáncia alimentìcia ou bebida adequada para consumo de mamìfero, e, creme, loção ou ungüento tópico
WO2008087348A3 (fr) Emulsion comprenant au moins un retinoide et du péroxyde de benzoyle
NO20090692L (no) Farmasoytiske og kostholdsprodukter som omfatter vitamin K2
NO20076019L (no) Utvortes preparat for hud
AU2013269583A8 (en) Oil/water-emulsion-type topical compositions containing a retinoid
AU2014359194A1 (en) Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology
RU2010120435A (ru) Пероральная композиция с эффектом, направленным против старения кожи
WO2008013669A3 (en) Alpha hydroxy acid sustained release formulation
WO2012130656A3 (de) Verfahren zur herstellung eines konditionierenden reinigungsmittels
RU2009101326A (ru) Препарат для наружного применения на кожу, содержащий тритерпеновую кислоту
CL2008003392A1 (es) Composicion que comprende: a) aceite de silicona, b) lipido, y c) agua, donde la composicion es una emulsion fluida de multiples fases; metodo para enfriar la piel y controlar el sudor en la piel mediante su aplicacion.
NO20084478L (no) Konjugerte lipidderivater
BRPI0413491A (pt) sistema de gordura vegetal hidrogenada
WO2009111688A3 (en) All-trans retinoid esters as active pharmaceutical ingredients, oral and topical dosage form compositions thereof, and methods of treating skin conditions thereof
TW200711663A (en) Emulsifier system, emulsion and use thereof
BR112015014187A2 (pt) composições de xantofila e métodos de uso
WO2014049561A3 (en) Oral composition for reinforcing skin tolerance following topical administration of a retinoid compound
DE502007005594D1 (de) Mascara mit einem Gehalt an synthetischen Wachs, Bienenwachs und synthetischen Esterwachs
UA113693C2 (xx) Титановмісна сполука, спосіб одержання титановмісної сполуки і застосування титановмісної сполуки в культивації рослин
WO2008111296A1 (ja) 角化の亢進に起因する皮膚疾患の予防及び治療のための医薬